Additional file 4 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer

  • Kuo-Chang Wen (Contributor)
  • Pi Lin Sung (Contributor)
  • TH Alexander Wu (Contributor)
  • Ping Chieh Chou (Contributor)
  • Jun-Hung Lin (Contributor)
  • Chi Ying F Huang (Contributor)
  • Sai Ching J. Yeung (Contributor)
  • Mong Hong Lee (Contributor)

Dataset

Description

Additional file 4: Figure S4. The effects of metformin in normal- or high-glucose culture medium. Western blotting was performed to assess the expression of AMPK, AKT, MTOR, 4E-BP1 and S6 following treatment with metformin, chemotherapy (carboplatin), or both for 48 h in the presence or absence of a high-glucose medium. Beta-actin was included as a loading control.
Date made availableJan 1 2020
PublisherUnknown Publisher

Cite this